Risk Factors for Early Mortality in Resected Localized Pancreatic Cancer
Identifying early mortality risks can guide surgical decisions in pancreatic cancer patients post-neoadjuvant treatment.
Newsletter
Every new paper in this field, in your inbox.
Identifying early mortality risks can guide surgical decisions in pancreatic cancer patients post-neoadjuvant treatment.
Immediate endoscopic necrosectomy (den) after drainage significantly speeds recovery in patients with necrotizing pancreatitis.
More accurate diagnosis is shifting surgical practice for abdominal pain and pancreatitis.
Lymph node yield significantly impacts overall survival and time to recurrence in node-negative pancreatic ductal adenocarcinoma after neoadjuvant therapy.
A new classification system helps predict pancreatic fistula risk after pancreatoduodenectomy.
Selective omission of operative drains in pancreatic surgeries doesn’t worsen perioperative outcomes.
Surgeons need to consider how perioperative quality of life fluctuates in pancreatic cancer patients to enhance outcomes.
Surgical resection significantly enhances survival in borderline resectable and locally advanced pancreatic cancer compared to continued oncology therapy.
This study shows that using a stapler for pancreatic transection in robot-assisted pancreaticoduodenectomy reduces clinically relevant postoperative pancreatic fistulas.
Non-benchmark patients with perihilar cholangiocarcinoma can achieve good outcomes despite higher complexity.